an exclusive license to develop and market chronic kidney disease drug Fosrenol (Lanthanum carbonate) in Japan. This drug was launched into the Japanese market in 2009. Shire began broadening into ...

Gasgoo Daily: BYD signs deals with Japanese local governments for disaster power supply High-Grade NPI and Refined Nickel Prices Remain Under Pressure Amid Weak Stainless Steel Market 【SMM ...

Year-End Backsheet Monthly Production Continues to Decline, Annual Market Outlook Not Optimistic [SMM Analysis] SMM Analysis on China November Silicon Metal Production and December Forecast [SMM ...